Background: Effective inhibition of platelet aggregation during PCI in high risk patients with ACS is of utmost importance. The new intravenous short acting P2Y-receptor inhibitor cangrelor is available for use in PCI-treated patients. We aimed to study platelet inhibition during treatment with cangrelor and transition phase with oral P2Y-receptor inhibitors in patients with acute coronary syndromes (ACS).

Methods: Cangrelor was administered during PCI to 21 P2Y-inhibitor naïve patients with ACS. Patients received a loading dose of ticagrelor at the time of procedure or prasugrel 30min before end of the cangrelor infusion. Platelet inhibition was measured by multiple electrode aggregometry (MEA) and thromboelastography (TEG), before and after PCI, immediately and 2h after stopping the infusion. Platelet inhibition after PCI was compared to a matched cohort of patients treated with oral P2Y-inibitors only.

Results: There was a significant reduction of platelet reactivity measured by MEA-ADP from 46.7U to 17.9U and by TEG MA ADP from 43.1mm to 22.0mm before infusion and after PCI respectively (p<0.001). There was also sustained platelet inhibition after stopping of cangrelor infusion and 2h later. Significant higher platelet inhibition was observed at the end of PCI in comparison to control cohort without cangrelor (MEA 17.9U vs. 54.2U, p=0.001).

Conclusion: We demonstrate significantly improved platelet inhibition during PCI in ACS patients treated with cangrelor in comparison to early treatment with potent oral P2Y-inhibitors. Cangrelor should be considered for periprocedural treatment of high risk patients with acute coronary syndrome.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2016.08.270DOI Listing

Publication Analysis

Top Keywords

platelet inhibition
16
p2y-inhibitor naïve
8
patients
8
naïve patients
8
patients acute
8
acute coronary
8
coronary syndromes
8
patients acs
8
infusion platelet
8
inhibition
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!